Literature DB >> 21869614

Usefulness of indocyanine green angiography to depict the distant retinal vascular anomalies associated with branch retinal vein occlusion causing serous macular detachment.

Tomoko Ueda1, Fumi Gomi, Mihoko Suzuki, Hirokazu Sakaguchi, Miki Sawa, Motohiro Kamei, Kohji Nishida.   

Abstract

PURPOSE: To report the usefulness of indocyanine green angiography (ICGA) to depict the retinal vascular anomalies associated with distant branch retinal vein occlusion resulting in serous retinal detachment at the macula.
METHODS: This was a retrospective, case series of 6 patients (6 eyes) with serous retinal detachments. Fluorescein angiography and ICGA showed that those 6 eyes had a distant branch retinal vein occlusion. The characteristics in ophthalmic examinations such as fundus appearance, fluorescein angiography, ICGA, optical coherence tomography, and clinical courses were evaluated.
RESULTS: In addition to serous retinal detachments, five eyes exhibited hard exudates around the macula. Fluorescein angiography and ICGA clearly showed the vessel occlusion; however, no apparent abnormalities appeared in the macular area in any of the eyes. In four eyes, early-phase ICGA depicted the retinal vascular anomalies within the area of venous occlusion and those were seen as hyperfluorescent patches on late-phase ICGA. In two eyes, punctate hyperfluorescent spots were seen in the area of venous occlusion on late-phase ICGA. Optical coherence tomography depicted a serous retinal detachment at the macula and retinal swelling in the outer nuclear layer from the macula to the hyperfluorescent abnormalities on ICGA. The macular serous retinal detachments were resolved within 3 months after laser photocoagulation was applied to the hyperfluorescent areas on ICGA.
CONCLUSION: Leakage from subsequent vascular anomalies after branch retinal vein occlusion can cause submacular fluid. Indocyanine green angiography is useful for detecting the causative vascular regions of the fluid.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21869614     DOI: 10.1097/IAE.0b013e31821c40a9

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  6 in total

1.  Decrease in the number of microaneurysms in diabetic macular edema after anti-vascular endothelial growth factor therapy: implications for indocyanine green angiography-guided detection of refractory microaneurysms.

Authors:  Kenichiro Mori; Shigeo Yoshida; Yoshiyuki Kobayashi; Keijiro Ishikawa; Shintaro Nakao; Toshio Hisatomi; Masatoshi Haruta; Tatsuro Isihibashi; Koh-Hei Sonoda
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-01-21       Impact factor: 3.117

2.  Subretinal leakage of a retinal capillary macroaneurysm - a case report.

Authors:  Ahmad S Rehmani; Touka Banaee; Fuad Makkouk
Journal:  BMC Ophthalmol       Date:  2021-05-17       Impact factor: 2.209

3.  Evaluation of Navigated Laser Photocoagulation (Navilas 577+) for the Treatment of Refractory Diabetic Macular Edema.

Authors:  Fusae Kato; Miho Nozaki; Aki Kato; Norio Hasegawa; Hiroshi Morita; Munenori Yoshida; Yuichiro Ogura
Journal:  J Ophthalmol       Date:  2018-05-02       Impact factor: 1.909

4.  Intraprocedural OCT monitoring of the immediate treatment response during indocyanine green angiography-guided laser therapy of teleangiectatic capillaries in diabetic macular edema.

Authors:  Felix Datlinger; Anja Datlinger; Andreas Pollreisz; Stefan Sacu; Ursula Schmidt-Erfurth; Peter Datlinger
Journal:  Sci Rep       Date:  2022-02-10       Impact factor: 4.379

5.  Visualization of microaneurysms in macular telangiectasia type 1 on optical coherence tomography angiography before and after photocoagulation.

Authors:  Mitsuko Nakai; Hisashi Iwami; Hisashi Fukuyama; Fumi Gomi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-10-02       Impact factor: 3.117

6.  Movement of intraretinal fluid from distant branch retinal vein occlusion to the submacular space.

Authors:  Tomohiro Otani; Yumiko Yamaguchi; Shoji Kishi
Journal:  Clin Ophthalmol       Date:  2013-01-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.